By Khushi Mandowara and Bhanvi Satija (Reuters) -UnitedHealth Group Inc on Friday topped expectations for first-quarter results but shares fell 3% after the company failed to address investor worries[...]
Read more
Health
Sarepta shares drop as report says FDA almost rejected under-review gene therapy
(Reuters) – Sarepta Therapeutics Inc’s shares fell as much as 19.4% premarket on Thursday as Stat News reported that the U.S. Food and Drug Administration’s staff were inclined to re[...]
Read more
World Bank steering committee, Yellen urge more reforms at lender this year
By Andrea Shalal WASHINGTON (Reuters) -The World Bank’s steering committee and U.S. Treasury Secretary Janet Yellen on Wednesday called for further reforms this year to expand the bank’s a[...]
Read more
Monster wins ban on Bang Energy’s ‘Super Creatine’ advertising
By Blake Brittain (Reuters) – Monster Beverage Corp, the maker of Monster Energy drink, on Wednesday persuaded a California federal court to block rival Vital Pharmaceuticals, maker of Bang Ener[...]
Read more
Juul to pay $462 million to six US states, D.C. over youth addiction claims
By Brendan Pierson NEW YORK (Reuters) -E-cigarette maker Juul Labs Inc agreed on Wednesday to pay $462 million over eight years to settle claims by six U.S. states including New York and California, a[...]
Read more
Novavax cut $50 million in costs, plans to slash more, CEO says
By Patrick Wingrove (Reuters) -Novavax Inc cut about $50 million in costs in the first quarter of 2023 and plans to slash more, Chief Executive John Jacobs said in an interview on Wednesday. “We’re lo[...]
Read more
JPMorgan asks senior bankers to return to office for five days a week – memo
By Lananh Nguyen and Niket Nishant (Reuters) -JPMorgan Chase & Co asked its managing directors to work from the office for five days a week, the largest U.S. bank said in a memo. “Our leader[...]
Read more
J&J talc unit faces skepticism on bankruptcy settlement support
By Dietrich Knauth (Reuters) – A Johnson & Johnson company on Tuesday defended its second attempt to resolve talc lawsuits in bankruptcy, telling a U.S. judge it can quickly build consensus[...]
Read more
Moderna fends off Arbutus appeal in COVID-19 vaccine patent fight
By Blake Brittain (Reuters) -A U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp patent related to the companies’ legal fight over[...]
Read more